Ferring Pharmaceuticals Inc. v. Fresenius Kabi USA, LLC
| FERRING PHARMACEUTICALS INC., FERRING INTERNATIONAL CENTER SA, FERRING B.V. and POLYPEPTIDE LABORATORIES A/S |
| FRESENIUS KABI USA, LLC |
| 23-1460 |
| February 3, 2023 |
| U.S. Court of Appeals, Federal Circuit |
| Patent - (ANDA) (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 9, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 14 Note to File: The following cases are consolidated: 23-1460 (Lead) with 23-1559 (Cross-Appeal). The parties must file all documents in the lead appeal only. [908986] [23-1460, 23-1559] [MMA] [Entered: 03/09/2023 04:50 PM] |
Filing 13
ORDER consolidating appeals (23-1460 and 23-1559). The revised official caption is reflected in the order. (See order for additional details). Service as of this date by the Clerk of Court. [908983] [23-1460, 23-1559] [MMA] [Entered: 03/09/2023 04:43 PM]
|
| Filing 12 Corrected Entry of Appearance for Imron T. Aly; Joel M. Wallace; Jason G. Harp as counsel for Appellee Fresenius Kabi USA, LLC. Service: 03/06/2023 by email. [908085] [23-1460] [Joel Wallace] [Entered: 03/06/2023 05:31 PM] |
| Filing 11 NOTICE OF NON-COMPLIANCE: The submission of Appellee Fresenius Kabi USA, LLC, Entry of Appearance [ # 8 ], is not in compliance with the rules of this court (see attached). Compliant document due on 03/13/2023. Service as of this date by the Clerk of Court. [908076] [MMA] [Entered: 03/06/2023 05:08 PM] |
| Filing 10 Docketing Statement for the Appellee Fresenius Kabi USA, LLC. Service: 02/28/2023 by email. [906993] [23-1460] [Joel Wallace] [Entered: 02/28/2023 10:09 PM] |
| Filing 9 Certificate of Interest for Appellee Fresenius Kabi USA, LLC. Service: 02/28/2023 by email. [906992] [23-1460] [Joel Wallace] [Entered: 02/28/2023 10:07 PM] |
| Filing 8 Entry of Appearance for Imron T. Aly; Joel M. Wallace; Jason G. Harp as counsel for Appellee Fresenius Kabi USA, LLC. Service: 02/28/2023 by email. [906991] [23-1460] This document is non-compliant. See Doc No. [ # 11 ] [Joel Wallace] [Entered: 02/28/2023 10:04 PM] |
| Filing 7 Notice to Appellee Fresenius Kabi USA, LLC: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Please file promptly . Service as of this date by the Clerk of Court. [906912] [MMA] [Entered: 02/28/2023 04:03 PM] |
| Filing 6 Corrected Certificate of Interest for Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 02/27/2023 by email. [906615] [23-1460] [Mary Bourke] [Entered: 02/27/2023 04:23 PM] |
| Filing 5 NOTICE OF NON-COMPLIANCE: The submission of Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S, Certificate of Interest [ # 3 ], is not in compliance with the rules of this court (see attached). Compliant document due on 03/02/2023. Service as of this date by the Clerk of Court. [905924] [CMH] [Entered: 02/23/2023 03:08 PM] |
| Filing 4 Docketing Statement for the Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 02/17/2023 by email. [904963] [23-1460] [Mary Bourke] [Entered: 02/17/2023 04:49 PM] |
| Filing 3 Certificate of Interest for Appellants Ferring B.V., Ferring International Center SA, Ferring Pharmaceuticals Inc. and Polypeptide Laboratories A/S. Service: 02/17/2023 by email. [904959] [23-1460] This document is non-compliant. See Doc No. [ # 5 ] [Mary Bourke] [Entered: 02/17/2023 04:46 PM] |
| Filing 2 Entry of Appearance for Mary W. Bourke (principal counsel); Dana K. Severance; John B. Bourke; Christian E. Mammen; Joshua P. Davis as counsel for Appellants Ferring Pharmaceuticals Inc., Ferring International Center SA, Ferring B.V. and Polypeptide Laboratories A/S. Service: 02/17/2023 by email. [904956] [23-1460] [Mary Bourke] [Entered: 02/17/2023 04:42 PM] |
| Filing 1 Appeal docketed. Received: 01/30/2023. [901875] Entry of Appearance is due on 02/17/2023. Certificate of Interest is due on 02/17/2023. Docketing Statement is due on 02/17/2023. Appellants' brief is due 04/04/2023. [CMH] [Entered: 02/03/2023 03:20 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
